Peptide therapeutics Forum
Biozentrum, University of Basel, Basel, Switzerland (Biozentrum, University of Basel Spitalstrasse 41 4056 Basel Switzerland)
Intavis Peptide Services is pleased to participate in the Peptide Therapeutics Forum 2026 (PTF26), taking place on June 4–5, 2026, at the Biozentrum of the University of Basel in Basel, Switzerland.
Organized under the umbrella of the Swiss Chemical Society, PTF26 is a leading European conference dedicated to peptide-based therapeutics. It brings together experts from academia, biotechnology, the pharmaceutical industry, and regulatory sectors to exchange insights and drive innovation in peptide drug development.
What to expect at the Peptide Therapeutics Forum 2026:
High-level scientific presentations on peptide discovery, design, and optimization
Insights into the preclinical and clinical development of peptide therapeutics
Discussions on emerging applications such as cancer vaccines, antimicrobial peptides, and innovative drug delivery strategies
Perspectives from industry and regulatory experts on the future of peptide-based medicines
Poster sessions and extensive networking opportunities with researchers and industry professionals
Intavis Peptide Services will be represented at the forum by Dr. Oliver Reimann (Head of Sales, Business Development & Marketing) and Dr. Van Tuan (Marco) Trinh (Sales Director). They will be available to discuss advanced peptide synthesis solutions and support innovation across the entire drug development pipeline.
Whether you are developing novel peptide-based therapeutics, seeking collaborations, or staying informed on the latest advancements, PTF26 provides a valuable platform to connect with key stakeholders in the global peptide community.
Order your peptides
Click order and a form will pop-up so you can enter your sequence directly. Alternatively upload a document listing your peptides or conjugates.